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Abstract:
Ambulatory clinical healthcare settings that serve patients infected with the
human immunodeficiency virus (HIV) are critical in improving access to quality
HIV care and treatment, in part due to their ability to streamline patient care
along the HIV care continuum. Barriers to HIV care are significant among newly
diagnosed HIV patients and in order to engage and retain these individuals in
care and treatment, specific interventions must be in place to link these
individuals to care. In this study, the difference in differences method was used
for data analysis to measure the impact of an ambulatory clinics intervention on
their newly diagnosed HIV patients in an effort to improve their retention in care
and HIV viral load suppression. The study participants all received their HIV
specific care and treatment solely at the University of Kentucky, Department of
Infectious Diseases HIV/AIDS Clinical Program (IMDP) that is a Ryan White
HIV/AIDS program funded ambulatory clinic. Of the 1,156 patients enrolled in the
IMDP clinic during the study, only 178 met the criteria for inclusion in the study.
This retrospective cohort study included data extracted from 178 patients’
electronic health records over a 24-month period, with 96 patients in the first 12month cohort and 82 patients in the second 12-month cohort. The differences in
means from the two data sets were analyzed for significance using the
Kolmogorov Smirnov two-sample test (KS) and p-value. The length of time
between readings of the biomarkers viral load and CD4+ T-lymphocyte cell count
at attended provider visits was statistically significant, suggesting that clients
exposed to the intervention with these readings less than 90 days apart were
more likely to have the recommended number of provider visits in a 12-month
period more than 90 days apart. No significant differences in visit spacing means
were found when controlling for viral load or CD4+ T-lymphocyte cell count.
Additionally, each cohort’s mean differences showed a positive trend towards
decreased viral load and increased CD4+ T-Lymphocyte cell count. Overall, this
study provided empirical evidence for more consideration towards implementing
HIV clinical interventions within large ambulatory clinical health systems that
improve health outcomes and retention in care for newly diagnosed HIV patients.
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INTRODUCTION
Individuals infected with the human immunodeficiency virus (HIV) are living
longer and experiencing improved quality of life due to scientific innovations in
antiretroviral therapy, and, as a result, they are achieving viral load suppression
sooner, which significantly reduces the risk of transmitting the disease (Doshi,
2015). Despite these scientific advances, over a million individuals in the U.S. are
living with HIV and only one in eight know that they are infected (Centers for
Disease Control and Prevention, Health Resources and Service Administration,
2014). Data from the Centers for Disease Control and Prevention (CDC),
displayed in Figure A, estimates that only 66 percent of individuals living in the
US diagnosed with HIV were linked to HIV care, and of those, only 25 percent
ever achieved viral load suppression (Centers for Disease Control and
Prevention, Health Resources and Service Administration, 2014). These
alarming statistics have garnered the attention of national government leaders,
healthcare facilities that offer HIV care, and healthcare providers. Consequently,
in 2010, President Barack Obama and his administration released the National
HIV/AIDS Strategy for the United States. The strategy seeks to reduce the
incidence rates of HIV, improve health outcomes for those living with HIV, reduce
disparities and inequities in healthcare for HIV care and treatment, and provide
healthcare facilities and providers a framework to move patients along the HIV
continuum of care (The Office of National AIDS Policy, 2015). The HIV Care
Continuum (Figure B) was established through an executive order by President
Barack Obama in 2013 and directed federal departments to prioritize increasing
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the number of individuals tested, diagnosed, linked and engaged in care, actively
on antiretroviral therapy, and achieving viral load suppression while implementing
(The White House Office of National AIDS Policy Executive Order, 2013).
Evidence suggests that an approach similar to that outlined in the HIV Care
Continuum may be an effective means to deliver services related to HIV
(Gardner E. M., 2011).
Retention in care, although challenging, is a critical step in the HIV continuum of
care and supports the patient achieving the desired outcome of viral load
suppression, and initiation of antiretroviral therapy (Mugavero & et.al., 2011). The
CDC defines it as the process of assisting persons with HIV to attend scheduled
follow-up HIV medical appointments after they have started HIV medical care
(Centers for Disease Control and Prevention, Health Resources and Service
Administration, 2014). The Institute of Medicine defines clinical recommendations
for retention outcomes as the patient attending two HIV medical visits with in one
year at least 90 days apart following new HIV diagnosis (Institute of Medicine of
the National Academies, 2012).
Ambulatory clinical settings provide a critical access point to take advantage of
the time interval between a patient’s HIV diagnosis and the initiation of
antiretroviral therapy (Irvine, 2015). This study used data from 178 newly
diagnosed HIV patients ages 18-64, enrolled in a Ryan White HIV/AIDS program
(RWHAP)

funded

clinic

in

a

large,

urban,

academic

medical

center

retrospectively followed over a 24 month period, to examine the impact of an
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retention in HIV care intervention on HIV biomarkers and the time periods
between HIV medical appointments.

METHODOLOGY
Study Design Overview
In this retrospective cohort study, data was collected from electronic medical
records of 178 newly diagnosed HIV patients enrolled in University of Kentucky
Department of Infectious Diseases HIV/AIDS Clinical Program (IMDP) which is
part of the University of Kentucky Healthcare system in Lexington, KY. Data from
the first cohort of patients, labeled Group A, was collected during a 12-month
period from June 1, 2013 through May 31, 2014. Data from the second cohort of
patients, labeled Group B, was collected from June 1, 2014 through May 31,
2015. In a response to improving their performance measures and attempting to
meet the recommended clinical guidelines for HIV Care by the National Health
Resources and Services Administration (HRSA), HIV/ AIDS Bureau, the clinic’s
continuous quality management (CQM) team developed an intervention. The
multifaceted intervention for a 12-month period involved linking individuals to
other medical and social support services, multiple case management sessions,
navigation assistance for enrolling on health insurance, and transportation
services to IMDP clinic provider visits. Group B was the only group exposed to
the intervention. The CQM team closely monitored every encounter with a patient
using an Excel spreadsheet to document each client’s date and attendance at
IMDP clinic provider visits, frequency of medical case management services
provided, and appointment reminders. Each patient from Group B was assigned
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to one CQM team clinical social worker (CSW), who managed the case
beginning at the patient’s initial visit to the IMDP clinic.

Study Population
Patients were referred to the IMDP clinic by an outside agency, hospital inpatient
follow-up for HIV specific care, or self-referral resulting from an inconclusive or
positive HIV-1 RNA oral antibody test. The IMDP clinic only serves clients who
live within its 68 county region, which includes majority of the counties on the
eastern half of the state of Kentucky (Figure C). The data included all newly
diagnosed HIV patients that were treatment naïve for antiretroviral therapy during
the period of June 1, 2013 through May 31, 2015.
Study inclusion criteria were: at least one new patient intake visit at the IMDP
clinic, blood serum confirmed HIV infection laboratory test, treatment naïve for
antiretroviral therapy, aged 18 to 64 years old, not pregnant and did not become
pregnant, die, discharge to palliative care, or become imprisoned during the
study period. Data elements included demographic information (Table 1);
attendance at all regularly scheduled provider visits at IMDP clinic, and recorded
labs results of every blood serum test for HIV viral load and CD4+ T-lymphocyte
cell count at each HIV provider visit. The IMDP clinic’s intervention included
improving the frequency of communication for newly diagnosed HIV patients in
an effort to improve their retention rates. The intervention increased the
frequency of CSW encounters for case management and in-person contacts for
appointment reminders. Criteria for encounters included the CSW’s facilitation of
any additional medical or support services (Table 5). Criteria for in-person
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contacts for appointment reminders included direct contact with the patient
through phone, email, or in-person at least one week before any scheduled
provider visit and follow-up for missed appointments at the IMDP clinic.
Patients’ electronic medical records were individually reviewed if the patient was
not retained in care (definition below) due to a self-reported move out of IMDP
service area, death, discharge to prison, or discharge to palliative care. If the
date of any of these incidents occurred during the study then the patient was
excluded from analysis of the data from that date forward.

Exposures and Outcomes
For the purpose of this study, the Institute of Medicines (IOM) standards for HIV
care were indexed to analyze the impact of the intervention on the outcomes for
retention in care, viral load suppression, and improved CD4+ T-lymphocyte cell
count. IOM defines, retention in care for newly diagnosed HIV patients, as
attending an infectious disease provider visit three times, at least 90 days apart,
in a 12-month period (Institute of Medicine of the National Academies, 2012).
The IMDP clinic’s protocol and procedures for clinical HIV care states that for
each provider visit ≥90 days apart that the provider order routine HIV labs for HIV
viral load and CD4+ T-lymphocyte cell count either the same date as provider
visit or one week before scheduled provider visit. A patient’s medical record with
at least three attended provider visits, ≥90 days apart during the study were
considered retained in care. If the patient’s medical record reported less than two
provider visits, ≥ 90 days apart they were not considered as retained in care.
When controlling for viral load and CD4+ T-lymphocyte cell count the duration of
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time between attended provider visits was analyzed to illustrate the impact of the
intervention on retention in care. Thus supporting how critical the time between
attended provider visits may affect retention in care and the patient’s progress
towards viral load suppression and improved immune system. Viral load
suppression and improved CD4+ T-lymphocyte are key biomarkers expressing
the impact of the intervention on retention in care (Doshi, 2015).
Viral load suppression as defined by IOM is a blood serum HIV-1 RNA viral load
less than or equal to 200 copies/mL each patient-year (Institute of Medicine of
the National Academies, 2012). The patient’s plasma HIV viral load and CD4+ Tlymphocyte cell count was recorded at each of these, as well as the baseline
values ≥90 days from their first IMDP clinic intake visit and when the patient
started anti-retroviral therapy. Patients with blood serum HIV viral loads ≤200
copies/mL were characterized as virally suppressed and assigned a value of 200
copies/mL for data analysis (Mugarvero, 2014). HIV viral loads greater than
10,000,000 copies were assigned to upper limit quantification of 10,000,000
copies per/mL. If a no viral load data was available for a patient during each 12month period, the patient was considered to have a viral load greater than 200
copies/mL and therefore were not considered virally suppressed based on the
IOM standards. If the patients’ medical records did not report at least two viral
load readings during the 12 month period, the patient was defined as not virally
suppressed and was recorded to have an HIV viral load greater than 200
copies/mL during the 12-month period.
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For further analysis of viral load suppression, the study captured each CD4+ Tlymphocyte cell count test ordered at every IMDP clinic provider visits. The CD4+
T-lymphocyte cell count is a biometric measure to gauge the improvement of the
patient’s immune system during first 12 months of care following new HIV
diagnosis. Patients with CD4+ T-lymphocyte cell count levels ≤200 cell/ mmᶟ
given a value of 200 cells/mmᶟ for data analysis purposes (U.S. Department for
Human and Health Services: HIV/AIDS Bureau, 2016). Any Improved CD4+ Tlymphocyte cell count reading greater than initial IMDP visit reading supports
viral load suppression and the impact of antiretroviral therapy for patients
retained in care (Mugavero M. R., 2012).
Statistical Analysis
Categorical data was analyzed using Kolmogorov Smirnov two-sample test (KS)
and p-values were computed. SAS software developed by SAS institute was
used to perform statistical computations using the difference in differences
method (DiD) to compare the difference in means for Groups A and Group B.
The primary outcome variables were viral load suppression, improved CD4+ Tlymphocyte cell count, and time between readings for viral load and CD4+ Tlymphocyte cell count. Multivariate and univariate logistic regression analysis
were performed at the end of the 12-month period for each cohort.
Experimental studies can underestimate critical factors that vary across times
and geographical statistics in order to identify casual effects of alternative
policies or interventions (Stuart, 2014). The DiD method aids in identifying these
causal effects by contrasting the change in outcomes pre- and post- exposure to
an intervention for a reference group and a comparison group. The method
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assumes that without exposure to the intervention the average outcomes of the
comparison group and the reference group would result in equivalent trends over
time. The difference-in-differences method (DiD) was used to analyze the
significance of the IMDP clinic’s recent intervention to improve its retention rate.
Analysis of both cohorts’ differences in means for viral load readings, CD4 Tlymphocyte cell count readings, and duration of time between provider
appointments was calculated using the KS two sample test. The p-value
generated from this KS analysis was evaluated to determine significance for
each outcome and specific period.
RESULTS
The study included 178 newly diagnosed HIV patients ages 18 to 64 who started
their HIV care and antiretroviral treatment at the IMDP clinic between June 1,
2013 and May 31, 2015. Gender at birth was 85 percent (n=151) male and 15
percent (n=27) female. Regarding HIV risk factors, 70 percent reported being
men having sex with other men, while eighteen percent reported their risk factor
as heterosexual exposure. Intravenous drug use (IDU) was, reported as a risk
factor by 2.25 percent, while another 2.25 percent reported two risk factors being
both as men who have sex with men and engage in IDU. The remaining 7.5
percent of risk factors were unknown or due to exposure to infected blood or
blood components. Furthermore, 75 percent of the full sample was white nonHispanic individuals, 15 percent Black/African American, 6 percent Hispanic or
Latino origin, and 4 percent other or unknown race/ethnicity. In addition, at the
time of the patient’s intake visit, 60 percent of the full sample had income levels
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below 100 percent of the federal

poverty level, 15 percent had no medical

insurance, and 50 percent of the full sample were actively enrolled in the
Kentucky Medicaid program as their primary source of medical insurance (Table
1).
Multivariate data analysis of CD4+ T-lymphocyte cell count and HIV viral load
using the difference in differences method found no significant difference
between Group A and Group B (Tables 2, 3). However, analysis of the duration
of time between readings of viral load and CD4+ T-lymphocyte cell count
combined found a significant difference between the Group A and Group B for
the first reading to the second reading (diff. 2.6, p <.0425) and from the first to
the third reading (diff. 10.4, p< .0019) (Table 4). Group A and Group B both
demonstrated trends for improved CD4+ T-lymphocyte cell counts, initiation of
antiretroviral therapy within 90 days of first reading, and progress towards viral
load suppression. Group A showed decreased mean viral load only in the first
and second readings (Table 2). Group B had significantly higher mean CD4+ Tlymphocyte counts and higher mean viral loads at the time of their initial intake
visit at IMDP clinic compared to Group A.

DISCUSSION
Retention in care and viral load suppression are key determinants in mortality
and morbidity for newly diagnosed HIV patients within the first 12 months
following diagnosis (Mugavero M. L., 2009). Ambulatory care clinics are the
front line of access to medical care for newly diagnosed HIV patients and
critical points of access to antiretroviral therapy (Irvine, 2015). Providing the
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needed infrastructure to equip ambulatory care clinics to move newly
diagnosed HIV clients through the HIV continuum of care in the first 12
months of diagnosis and then long-term is a critical factor in reaching the
goals and objectives of the U.S. HIV /AIDS strategy and HIV/AIDS prevention
efforts (Mayer, 2011). The difference in differences analysis provided a
methodology for analysis of one ambulatory clinic’s intervention to improve
health outcomes for their newly diagnosed HIV patients. The analysis did not
find significance differences between means for viral load suppression and
CD4+ T-lymphocyte cell count, but there was a positive trend for both cohorts
towards expected outcomes of decreased viral load and improved CD4+ cell
T-lymphocyte cell count, suggesting that other variables may be impacting the
results. Another method to evaluate significance, such as a McNemar
comparison with logistic regression analysis, might have different results.
Because of the complexity of the HIV disease, it is often difficult to evaluate
interventions using randomized controlled trials (Gardner, 2014). The
difference-in-differences method allowed for before-and-after analysis of the
differences in means for this intervention in an ambulatory setting, similar to
those often found in large urban or academic medical campus healthcare
systems. Although for this study, the method may not have been as effective
in identifying significant differences between the means from Group A and
Group B, the desired outcomes for decreased viral load and improved CD4+
T-lymphocyte cell count showed positive trends over each 12-month period.
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A poor retention in care rate is an important indicator that the patient is not
progressing along the HIV continuum of care (Giordano, 2007). Although
challenging, retention in care for newly diagnosed HIV patients improves
quality of life, CD4+ T-lymphocyte cell count, the likelihood the patient will
receive the maximum benefits of antiretroviral therapy, and the patient’s
progress towards achieving viral load suppression (Centers for Disease
Control and Prevention, Health Resources and Service Administration, 2014).
It is imperative to find more interventions that fill the gaps in HIV delivery of
care and support ambulatory clinics with evidence-based practices that
progress newly diagnosed HIV patients along the HIV continuum of care
within the first 12 months of diagnosis.
Limitations of the study
This study has several limitations. First, it is a retrospective cohort study of a
single ambulatory clinic, which limits the generalizability of its findings to other
HIV populations. The IMDP clinic is one of six RWHAP-funded ambulatory
clinics in Kentucky, and further research on retention in care and viral load
suppression for newly diagnosed clients from other ambulatory clinics in
Kentucky and other states could add to the study’s findings. A second
limitation is that the study could have missed patients that moved out of the
IMDP service area during the study. Thirdly, missing viral load data during
each 12-month period was recorded as not being virally suppressed when in
fact the patient could have achieved viral load suppression during the study.
Fourth, because the clinic receives patients on a referral basis for Kentuckians
who live in its region, the clients who were self-referred or had a partner who
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receives HIV care at the clinic may have been more motivated to stay
engaged in care at the IMDP clinic. This limitation could influence the results
for retention in care, viral load, and CD4+ T-lymphocyte cell count. Finally, the
lack of control for data from the CSW encounters and personal contacts
provided to Group B may have given rise to an undetected correlation
between specific types of encounters and their impact on retention in care and
viral load suppression.
Future Direction and Research
HIV is a complex long-term illness that requires innovative and effective
strategies to improve access to care, linkage, retention in care, long-term
engagement in care, and initiation and continued use of antiretroviral therapy in
order to produce positive health outcomes in persons living with the disease
(Marks, 2010). This study presented one organization’s strategies to improve
retention in care for their newly diagnosed patients. Future research on this data
could assess the impact of confounding variables such as patient wait times,
provider availability, demographic statistic, time between scheduled and rescheduled appointments, smaller or larger healthcare systems, and the time
between initiation of antiretroviral therapy and viral load suppression. When the
third readings were recorded for both groups, there was a declining trend in the
number of patients with recorded provider visits ≥240 days from initial IMDP clinic
visit and viral load results. This suggests that several clients might have fallen out
of care, a finding that deserves further exploratory research in longitudinal
studies and cross-sectional studies. Longitudinal studies could further research
by exploring interventions that impact retention in care rates and viral load
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suppression at 24, 36, 48, or 60 months. Finally, it would be beneficial to study
interventions that work in different healthcare settings and vulnerable populations
to address patient-specific barriers to care such as transportation assistance,
access to medical insurance, HIV stigma, travel distance to clinic, voucher
incentives, and access to behavioral health services.
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APPENDIX: Tables and Figures

Table 1. Descriptive Statistics
VARIABLE
Number of individuals in sample
Age at Intake (mean)
sd
Race/Ethnicity
white NH
african american NH
asian pacific island NH
hispanic
Gender at Birth
female
male
Risk Factor
heterosexual
IDU
MSM
MSM+IDU
unknown/undetermined
Percent Federal Poverty Level
100% FPL
133% FPL
150% FPL
185% FPL
200% FPL
300% FPL
400% FPL
>400% FPL
Insurance Coverage
no insurance
Medicaid
BCBS
other types

Full Sample
178
34.4
15.6

20

Group A

Group B

96
35.2
10.7

82
33.5
19.9

130
28
5
15

69
14
3
10

61
14
2
5

27
151

19
77

8
74

33
5
125
4
11

18
4
68
1
5

15
1
57
3
6

111
3
5
5
10
9
5
3

58
1
4
5
4
3
4
2

53
2
1
0
6
6
1
1

27
89
31
31

15
50
16
15

12
39
15
16

Table 2. Method Results for CD4+ T-lymphocyte cell count (uL)
CD4 Levels (mean uL)
First Reading
std.dev
non-missing obs
Second Reading
std.dev
non-missing obs
Third Reading
std.dev
non-missing obs
Change from 1st to 3rd Reading
sd
non-missing obs

Full Sample
509
324
155
518
297
149
561
329
123
102
117
117

Group A
505
333
81
496
284
76
562
361
60
110
175
57

Group B
Difference p-value
513
8 0.8735
316
74
541
44 0.3633
310
73
559
-3 0.9592
299
63
94
-16 0.6309
183
60

Table 3. Method Results for HIV-RNA 1 Viral Load (copies/mL)
Full Sample
Viral Load (mean copies/mL)
First Reading
std.dev
non-missing obs
Second Reading
std.dev
non-missing obs
Third Reading
std.dev
non-missing obs
Change from 1st-3rd Reading
std.dev
non-missing obs

32,615
188,881
168
7,584
33,026
151
3,216
17,520
122
40,118
221,765
121
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Group A
25,653
123,932
92
6,457
27,684
79
3,251
15,749
60
34,590
153,091
60

Group B
41,043
246,315
76
8,820
38,202
72
3,182
19,208
62
45,556
274,322
61

Difference

p-value

15,390

0.6214

2,364

0.6666

-69

0.9827

10,967

0.7861

Table 4. Method Results for duration of time between readings for viral
Load and CD4+ cell count combined
Duration between readings
(number of weeks)
Intake to 1st reading
sd
non-missing obs
1st reading to 2nd reading
sd
non-missing obs
2nd reading to 3rd reading
sd
non-missing obs
Intake to 3rd reading
sd
non-missing obs

Full Sample
14.9
10.6
160
13.1
8.1
155
17.1
11.0
126
41.1
18.8
123

Group A
13.6
9.2
84
11.8
7.2
81
16.3
10.7
62
35.8
18.0
61

Group B
16.3
11.9
76
14.4
8.8
74
17.8
11.2
64
46.2
18.4
62

Difference

p-value

2.7

0.1113

2.6

0.0425

1.5

0.4354

10.4

0.0019

Table 5. Encounters Provided by IMDP Clinical Social Workers
Referral for Behavioral Health
Referral for State AIDS Drug Assistance Program
Partner Testing and Counseling
Sexual Education and Condom Use
Risk Reduction counseling
Transportation Assistance
Social Support Services
Food Bank Agency Referrals
Medication Copay Assistance
Assistance for Durable Medical Equipment
Medical Insurance Premium Assistance
Navigation to enroll in state Health benefit exchange program or Medicaid
Tobacco Cessation Counseling
Substance Abuse Treatment Referral
Medication adherence counseling
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Figure A: 2011 CDC Analysis: The Continuum of Engagement in HIV Care (Centers for
Disease Control and Prevention, 2014)
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Figure B. The Continuum of Engagement in HIV medical care
(Centers for Disease Control and Prevention, 2014).

Figure C. University of Kentucky Department of Infectious Diseases HIV/AIDS
Clinical Program (IMDP) Service Area Map (University of Kentucky, College of Medicine, 2015)
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